This study investigated the presence of risk factors and complications in the newly referred patients to our diabetes clinic. It also looked into how these risk factors and complications were being managed as compared to existing guidelines and evidence. In the present study 58 diabetic patients were included, 24 % (14/58) were smokers, 55% (32/58) were obese and 27 % (15/58) were overweight. Mean total cholesterol/HDL ratio was 4.52 and mean HbA1c was 8.29. Out of 49 type 2 diabetic patients 57.1% (28/49) patients were hypertensive and 50% (14/28) patients were on 3 or more antihypertensive drugs. Twenty of forty nine (40.8%) type 2 diabetic patients had high microalbumin/creatinine ratio and 55% (11/20) of them were on ACE inhibitors. In the type 2 diabetic group 85.7 % (42/49) were either overweight or obese and 40.4% (17/42) of these patients were on metformin. Thirteen of fifty eight patients (22 %) had ischaemic heart disease; and 22% (13/58) had total cholesterol/HDL ratio > 3.9 out of whom 31% (4/13) were on statins. All patients who were smokers received advice on stopping smoking and were offered counseling services and nicotine patches/bupropion by their General Practitioners.

Keywords:
risk factors, diabetes, complications, patients
This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2004
You do not currently have access to this content.